Margaret S. Lee

机构：Boston University · ORCID：0000-0003-0421-6290

发表论文 279 篇 · 总被引 6789 次 · h-index 31

代表论文

• Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial (2023 · The Lancet · 被引 1156)
• Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial (2025 · Nature Medicine · 被引 129)
• Now, Women Do Ask: A Call to Update Beliefs about the Gender Pay Gap (2023 · Academy of Management Discoveries · 被引 53)
• Unified framework for patient-derived, tumor-organoid-based predictive testing of standard-of-care therapies in metastatic colorectal cancer (2023 · Cell Reports Medicine · 被引 43)
• SCORE: a randomised controlled trial evaluating shared care (general practitioner and oncologist) follow-up compared to usual oncologist follow-up for survivors of colorectal cancer (2023 · EClinicalMedicine · 被引 27)
• The association of body composition on chemotherapy toxicities in non‐metastatic colorectal cancer patients: a systematic review (2023 · ANZ Journal of Surgery · 被引 24)